News
7/7/2017

CRG: Big data to pave the way for precision medicine in Alzheimer’s disease and lung cancer

CRG: Big data to pave the way for precision medicine in Alzheimer’s disease and lung cancer


News from CRG


CRG researchers participate in the IASIS project, which is a new European research project aiming to turn health data into personalised treatments for Alzheimer’s disease and lung cancer patients. The project has been launched including the European Genonome and Phenome Archive (EGA) team at the CRG, as well as researchers from Gian Gaetano Tartaglia’s laboratory.

The goal of IASIS (acronym for “Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients”) is to turn large amounts of valuable data into a robust evidence base to help guide public health policy and help pave the way for more personalised treatment approaches. In an age of big data, there are now valuable data collections that could give crucial insight into the development of these diseases and the effectiveness of personalised treatment approaches for each patient.

However, the ability to integrate and analyze these different types of data has so far proved to be a challenging undertaking. With €4.3m funding from the European Commission, this project seeks to address this challenge. Bringing together partners from 10 research organisations in five countries, this collaborative initiative will combine and analyze data that has been collected through a number of existing studies, such as health records, DNA samples and imaging data. The contribution of IASIS lies in the way in which the different types of data will be analyzed and brought together into a common knowledge base. 

More information:
CRG website